A detailed history of Granite Harbor Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Granite Harbor Advisors, Inc. holds 1,236 shares of LLY stock, worth $948,951. This represents 0.63% of its overall portfolio holdings.

Number of Shares
1,236
Previous 574 115.33%
Holding current value
$948,951
Previous $520 Million 110.71%
% of portfolio
0.63%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$772.14 - $960.02 $511,156 - $635,533
662 Added 115.33%
1,236 $1.1 Billion
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $2,899 - $3,636
-4 Reduced 0.69%
574 $520 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $4,145 - $5,545
-7 Reduced 1.2%
578 $450 Million
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $21,007 - $24,765
40 Added 7.34%
585 $341 Million
Q2 2023

Nov 17, 2023

BUY
$350.74 - $468.98 $191,153 - $255,594
545 New
545 $256 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Granite Harbor Advisors, Inc. Portfolio

Follow Granite Harbor Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Harbor Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Granite Harbor Advisors, Inc. with notifications on news.